Introduction
The nucleolar Arf protein (p19 ARF in mouse or p14 ARF in human) binds to mdm2 to activate the growth suppressive functions of p53 in the control of the cell cycle. In the absence of p53, Arf still exerts its tumor suppressor function through mechanisms implying other regulators (Carnero et al., 2000; Weber et al., 2000) . In this context, p14
ARF has been shown to interact with E2F1 and inhibits its transcriptional activity (Eymin et al., 2001 ). More recently a role for Arf in the control of ribosome biogenesis has been suggested: p19 ARF delays rRNA processing in a mdm2 and p53-independent manner (Sugimoto et al., 2003) and associates in very high molecular weight complexes with NPM/B23, a protein involved in the maturation of preribosomal particles (Bertwistle et al., 2004) . The human homologue p14 ARF has been shown to partially colocalize with NPM/B23 in the granular component of the nucleolus and to induce its degradation, resulting in the inhibition of rRNA levels and cell death induction (Lindstrom et al., 2000; Itahana et al., 2003) .
Biogenesis of ribosomes in the nucleolus is highly regulated in eukaryotic cells to manage accurate cell growth and proliferation. Conditions that harm cellular metabolism are accompanied by profound, but reversible, changes in the rate of rRNA genes transcription. During cell cycle progression in mammals, rRNA transcription levels are finely regulated, high in the S and G2 phases they shut down in mitosis and progressively increase in G1 (Pardee, 1989; Grummt, 1999; Klein and Grummt, 1999) . The regulation of cell growth and proliferation via the production of ribosomes can also be controlled at later stages, during rRNA processing or ribosome assembly.
We had previously described the existence of an interaction between p14 ARF and the topological enzyme Topoisomerase I (Topo I), essential in the transcription of supercoiled rRNA genes (Garg et al., 1987; Karayan et al., 2001; Ayrault et al., 2003) . More recently, we have demonstrated by ChIP experiments that p14 ARF protein was able to specifically interact with the human rRNA promoter in the presence of Topo I (Ayrault et al., 2004) . These results are consistent with a role for the human Arf protein in rRNA transcription.
A key regulator for the transcription of the 47S/45S pre-RNA by the RNA polymerase I (Pol I) is the transcription factor UBF (upstream binding factor) (for a review see Grummt, 1999) . Activation of UBF by phosphorylation can result, either from mitogenic signals that stimulate the MAP kinase signaling pathway (Stefanovsky et al., 2001) , or from cell cycle regulation process involving casein kinase II (CKII) or CDK-cyclin complexes (Voit et al., 1992 (Voit et al., , 1999 Voit and Grummt, 2001 ). All these kinases have been found overexpressed in many cancers. Several tumor suppressors have also been shown to directly interact with UBF: pRb or p130 inhibit in that way subsequent recruitment of cofactors required for rRNA transcription (Cavanaugh et al., 1995; Voit et al., 1997; Hannan et al., 2000a, b; Ciarmatori et al., 2001) . p53 also interferes with Pol I activity by destabilizing the SL1-UBF complex required for transcriptional initiation on the rRNA promoter (Zhai and Comai, 2000) .
We show here that human p14 ARF inhibits Pol I-dependent transcription of ribosomal RNA in vitro as well as in vivo and specifically associates with the transcription factor UBF. In return, UBF is hypophosphorylated upon p14 ARF expression thus unable to recruit other factors to constitute the transcriptional complex. We failed to demonstrate any involvement of the p14 ARF /Topo I complex in this inhibition, despite the major role assumed by Topo I in the relaxation of the rRNA promoter region leading to the transcription of the 47S rRNA precursor.
Results

The human p14
ARF protein binds to the promoter of rRNA and decreases its activity We have recently reported the existence of a specific interaction between the nucleolar p14 ARF protein and chromatin enriched in rRNA promoter sequence, suggesting that p14 ARF could participate in the regulation of rRNA transcription, potentially in relation with the control of cell cycle. To investigate this hypothesis, experiments were performed using the H358 cell line issued from a human bronchioalveolar carcinoma that expressed low levels of endogenous p14 ARF . In these cells, p53 is inactivated by homozygous deletion. p14 ARF overexpression leads to cell cycle arrest and apoptosis: a 50% decrease in cell number is observed between control cells and p14 ARF overexpressing cells after 1 week (Eymin et al., 2003) .
To determine whether p14 ARF could modulate rRNA promoter activity, we performed transient transfections followed by luciferase activity assays using the Dual Luciferase Reporter Kit (Promega). Protein expression was first analysed by Western blot: endogenous p14 ARF is slightly detected in mock lane, whereas pcDNA3.1-p14 ARF transfected cells express 7-to 8-fold higher p14
ARF protein according to signal measurement using ScanImage Beta4.02 software (Figure 1a) . The pHrDNA-IRES-Luc plasmid was constructed by cloning the À410 to þ 314 region of the human rRNA promoter in the pGL3 vector under the control of the internal ribosome entry site (IRES). To minimize expression driven by spurious Pol II promoters within the plasmid, the Kozak sequence was deleted. This construct and its specificity have been previously validated (Ghoshal et al., 2004) . 
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Relative Luciferase Activity (%) ARF is slightly detected in mock control by comparison with ectopic protein expression (7-to 8-fold increase). Signal quantification was deduced from scanning measurement using the ScanImageBeta 4.02 software. (b) Human rRNA promoter activity. The pIRES-Luc or pHrDNA-IRES-Luc plasmid along with the internal control pRLTK, and either pcDNA3.1 (mock) or pcDNA3.1-p14 ARF , were transfected into H348wt cells. After 24 or 48 h, both firefly and renilla luciferase activity were measured using Dual Luciferase assay kit (Promega). Transfection of empty pcDNA3.1 þ pRLTK and either pIRES-Luc or pHrDNA-IRES-Luc allow to calculate the ratio (pHrDNA-IRES-Luc/pRLTK)/(pIRES-Luc/pRLTK), which is normalized to 100% luciferase activity (mock). Negative control was obtained by treatment of the cells for 24 h with 5 mM Cpt, an inhibitor of Topo I required for rRNA transcription. Average values from three independent experiments are graphically represented. Cell cycle analysis was performed in parallel to demonstrate that the decrease in luciferase activity was not due to extensive cell death or cell cycle inhibition.
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Mock control (Figure 1b ) corresponds to H358wt cells co-transfected with empty pcDNA3.1 plus pRLTK (internal luciferase activity reporter, see Materials and methods) and either pIRES-Luc (promoter-less, as negative control) or pHrDNA-IRES-Luc vector. The ratio (pHrDNA-IRES-Luc/pRLTK)/(pIRES-Luc/ pRLTK) in these conditions is normalized to 100% luciferase activity and corresponds to the promoter activity in control cells (mock).
As preliminary negative control, cells transfected as described above were treated for 24 h with 5 mM camptothecin (Cpt), an inhibitor of Topo I, whose catalytic activity is required for the transcription of supercoiled rRNA genes, to ascertain that luciferase expression was strictly dependent on the rRNA promoter activity. Indeed, Cpt treatment induced a strong inhibition of luciferase activity (90%), attesting that luciferase activity from pHrDNA-IRES-Luc in H358 cells was driven by the rRNA promoter and involved Pol I (Figure 1b) . Moreover, internal luciferase activity (pRLTK) was not modified upon Cpt treatment attesting that the inhibition observed was not the consequence of an extensive cell death.
In parallel, H358wt cells were co-transfected with pcDNA3.1-p14 ARF plus pRLTK and either pIRES-Luc or pHrDNA-IRES-Luc vector. Luciferase activity was measured as described above, 24 and 48 h after transfection (Figure 1b) . The inhibitory effect observed was dependent on p14 ARF expression: a 30% reduction was observed 24 h after transfection compared to the mock control and this inhibition raised-up to 70% after 48 h. Under these experimental conditions, no significant modification of the cell cycle was observed between control (mock) and transfected cells (48 h) (Figure 1b) .
Taken together, these results were consistent with a role for p14 ARF in the regulation of rRNA transcription in vitro. To confirm these data, luciferase assays were next performed using a H358/TetOn/p14 ARF inducible clone (clone 19) (Eymin et al., 2003) (Figure 2a ). In these cells, p14 Arf protein expressed upon E2F1 activation inhibits rRNA promoter activity Arf protein can be stimulated in response to inappropriate proliferative signals in vivo (E1A, E2F1, rasy). To induce such conditions, the assays presented below were performed with H358wt cells transiently transfected with a recombinant pcDNA3.1-E2F1 vector (0.5 or 1 mg). At 48 h after transfection, E2F1, Arf and actin expression were detected by Western blot and quantification of the signal was performed (Figure 2b, top) . Upon transfection of 0.5 mg of pcDNA3.1-E2F1 vector, E2F1 expression was too weak to overexpress Arf protein and, accordingly, luciferase activity was referred as 100% (Figure 2b, bottom) . In contrast, Arf overexpression via E2F1 (1 mg) was correlated with an inhibition of luciferase activity (50% decrease), suggesting that the decrease of the rRNA promoter activity was dependent on the levels of p14 ARF . Experiments aimed at inducing endogenous Arf expression through E2F1 proliferative signal, gave the same results as those obtained by transient transfections or stable clones induction. These data strongly reinforce the notion that Arf physiologically regulates rRNA promoter activity.
Arf overexpression affects the formation of the 47S rRNA precursor To further investigate the role of Arf in the control of rRNA transcription, we next examined whether rRNA synthesis was modulated by Arf expression in vivo. H358wt cells were transiently transfected with pcDNA3.1-p14 ARF vector or empty vector (mock). At 72 h after transfection, cells were metabolically labeled with [
3 H]Uridine for 30 min followed by a 2 h chase. To analyse the accumulation of full-length 47S rRNA precursor, equal amounts of total RNAs were run in a formaldehyde agarose gel. Ethidium bromide staining allowed the characterization of 47S and 32S precursors and subsequent mature 28S and 18S rRNAs (Figure 3a , left). Scanning of the gel confirmed that equal amounts of total RNA and 47S rRNA precursor were present on each sample (Figure 3a, right) . Northern blot autoradiography was performed (Figure 3b , left) and scan measurements were performed on three independent experiments, indicating that labeled 47S rRNA amounts were twofold higher in cells without p14 ARF (Figure 3b , right). The fact that similar amounts of uridine incorporation are observed in the 32S rRNA in mock and pcDNA3.1-p14 ARF transfected cells, indicates that lower uridine incorporation in the 47S rRNA is not the consequence of an increase processing of the latter. These data suggest that the presence of the human Arf protein is able to affect rRNA synthesis either by reducing or delaying the transcription process.
We have previously reported the existence of a physical and functional complex between p14 ARF and Topo I leading to an increased endonucleolytic Topo I activity Ayrault et al., 2003) . Moreover, p14 ARF and Topo I are both recovered in the chromatin fraction containing the rRNA promoter (Ayrault et al., 2004) , in accordance with the requisite role of Topo I in rRNA transcription through the relaxation of supercoiled rDNA (Garg et al., 1987) . We examined the possible involvement of p14 ARF in cell cycle arrest through both its activation of Topo I catalytic activity and inhibition of rRNA transcription. Whereas immunoprecipitation experiments revealed that detection of the p14 ARF /Topo I complex was strictly correlated with cell cycle arrest in H358/TetOn/p14 ARF induced cells, we were unable to demonstrate that the rDNA promoter inhibition was due to the p14 ARF -dependent activation of Topo I as an apoptotic endonuclease (data not shown).
The transcription factor UBF is a new partner of p14 ARF To address the mechanism by which p14 ARF participates in the negative regulation of Pol I-dependent rRNA transcription, the putative association of p14 ARF with proteins of the transcriptional complex was analysed. , dried membranes were treated with En 3 hance (Perkin-Elmer life Sciences, Boston, MA, USA) and subjected to autoradiography using intensifying screens. Radioactivity intensity levels of neo-synthesized 47S from three independent experiments are presented on the histogram.
ARF negatively regulates rRNA transcription O Ayrault et al A key regulator for rRNA genes transcription is the UBF factor (Voit and Grummt, 2001) . UBF binds to the upstream control element (UCE) and core sequences within the rRNA promoter and directly associates with Pol I, thus tethering the enzyme to the promoter complex. First, cellular localization of UBF and p14 ARF was assessed by indirect immunofluorescence. As expected, both proteins were detected in the nucleolus. (Figure 4a) , two bands corresponding to UBF1 (97 kDa, Pol I specific factor) and UBF2 (94 kDa) species were detected. In 293 cells that express abundant levels of endogenous p14 ARF , the same results were observed ( Figure 4b) .
As both p14 ARF and UBF interact with the same UCE and core regions within the rRNA promoter, UBF expression was analysed in H358/TetOn/p14 ARF cells (clone 19) after 0 h (À) or 96 h ( þ ) of doxycyclin treatment. Immunoprecipitations were performed in parallel, on the same cell extracts, revealing that increasing amounts of UBF1-p14 ARF complexes were detected in cells undergoing cycle arrest ( þ ), whereas UBF2-p14 ARF complexes were stable (Figure 4c ). The presence of a possible ternary complex associating UBF, ARF and Topo I was also examined, but immunoprecipitation experiments failed to detect any interaction between Topo I and UBF1 or UBF2 (Figure 4d ).
UBF1 is hypophosphorylated upon Arf expression
UBF1 activity is regulated during cell cycle via phosphorylation by different kinases (Voit et al., 1999; Drakas et al., 2004) . In quiescent cells, UBF1 is hypophosphorylated and transcriptionally inactive (Voit et al., 1992) . To examine the involvement of the p14 ARF / UBF1 complex in the negative regulation of the rRNA promoter activity, we first compared by Western blot UBF1 phosphorylation in H358wt cells transfected with pcDNA3.1-p14 ARF or an empty pcDNA3.1 vector for 72 h (Figure 5a ). Interestingly, enhanced p14 ARF expression appeared to be correlated with a 66% decrease in the UBF phosphorylation levels (Serine 484 (Ser-484)) while total UBF expression was identical 72 h after transfection (Figure 5a) . Same experiments were then performed with H358/TetOn/p14 ARF clone 19 cells induced by doxycyclin. Again, Western blot analysis demonstrated that p14 ARF induction was in inverse ratio to phosphorylated-UBF1 on both Ser-484 and Ser-388. In the meantime, total UBF was not modified (Figure 5b, top) . Relative protein expression was quantified and results are summarized on a diagram that clearly illustrates that UBF phosphorylation is inhibited upon p14 ARF induction (Figure 5b , bottom).
UBF overexpression is able to correct the Arf-induced inhibition of rRNA promoter activity As our results showed that UBF1 hypophosphorylation, upon Arf expression, was associated with a reduction of the 47S rRNA transcription, UBF overexpression was expected to balance this effect. To test this hypothesis, luciferase experiments were performed on H358wt cells transfected with pcDNA3.1 as control, pcDNA3.1-p14 ARF alone, or pcDNA3.1-UBF1 plus pcDNA3.1-p14 ARF ( Figure 6 ). As previously shown, Arf expression led to a 50% decrease in the rRNA promoter activity. In contrast, the promoter is significantly activated (1.8-fold to the control) upon ectopic UBF1 expression. These data demonstrate that UBF1 is able to correct the negative consequence of Arf expression on rRNA transcription, and strongly reinforce the notion that Arf can exert its tumor suppressor function on different levels of ribosome biogenesis.
Discussion
We have recently reported the existence of a specific interaction between the nucleolar p14 ARF protein and chromatin enriched in rRNA promoter sequence. These results were in accordance with the notion that p14 ARF (clone 19) cells were cultured with 1 mg/ml Doxycyclin (Doxy) for indicated times. Same amounts of total protein extracts were analysed by Western blot, using antibodies against p14 ARF (C18, Santa Cruz Biotechnology), UBF (H-300, Santa Cruz Biotechnology), p-UBF(Ser 484) and p-UBF(Ser 388) (Santa Cruz Biotechnology) and actin (AC-74, SIGMA). Blots were scanned as above to quantify protein amounts, results are graphically represented.
p14
ARF negatively regulates rRNA transcription O Ayrault et al overexpressed upon oncogenic signals, suggesting that the protein could exert at least part of its tumor suppressor activity in that compartment. We now report that, through its interaction with the rRNA promoter, p14 ARF participates in the inhibition of rRNA transcription. Moreover, this inhibition is correlated with a decrease in the phosphorylation of the Pol Ispecific transcription factor UBF1, leading to its inability to initiate the formation of the transcriptional complex.
To study the consequences of p14 ARF binding on the rRNA promoter, we first performed luciferase assays in H358 cells. The luciferase reporter plasmid contains a region spanning from À410 to þ 314 bp comprising the UCE, the core promoter and part of the external transcribed spacer region 1 (ETS1) (Ghoshal et al., 2004) . Direct expression of p14 ARF was obtained by transient transfection of pcDNA3.1-p14 ARF in H358 cells and luciferase assays revealed that p14 ARF was able to significantly reduce the activity of the human rRNA promoter. This inhibition is not due to either proliferation arrest or apoptosis in response to transfection toxicity or/and p14 ARF overexpression, as demonstrated by cell cycle analysis. Identical results were observed with H358/Tet-on/p14 ARF cells after induction of p14 ARF by doxycyclin. The delay necessary to induce the promoter inhibition can suggest that other partners are probably involved in this mechanism and have to be recruited. To mimic cell response to oncogenic stimuli, luciferase experiments were performed on H358wt cells upon ectopic expression of the transcription factor E2F1. E2F1 has been shown to upregulate Arf expression (Bates et al., 1998) and in response, p14 ARF inhibits E2F1 transcriptional activity in vitro (Eymin et al., 2001) . In these transfected cells, p14
ARF expression upon the promoter activity was inhibited (50%). These results not only comfort the ability for p14 ARF to regulate the rRNA promoter activity in vitro, but also confirm the dose-dependent effect of this regulation. To assert these results in vivo, de novo transcription of rRNA was analysed by pulse-chase experiments and Northern blotting. 47S rRNA levels, estimated using ScanImage b2.4 software, were 50% reduced in vivo upon Arf expression. In contrast, an equivalent amount of uridine incorporation is found in the 32S rRNA, demonstrating that the reduction observed for the 47S synthesis is likely due to the reduction of rRNA promoter activity rather than to the activation of the rRNA processing mechanism.
Taken together, these data raise the possibility that p14 ARF could negatively regulate malignant progression by altering ribosome biogenesis at early stage. However, this regulation on its own is clearly not sufficient to inhibit cell proliferation. In this context, p19
ARF and p14
ARF have been recently identified as inhibitors of ribosomal processing through their interaction with both B23/nucleophosmin and 5.8S (Lindstrom et al., 2000; Eymin et al., 2003; Sugimoto et al., 2003) . B23 possesses an intrinsic endoribonuclease activity involved in the processing of the 32S rRNA into the mature 28S subunit (Savkur and Olson, 1998) . According to Sugimoto et al. (2003) , the murine homologue p19 ARF could delay 32S maturation through a physical interaction with mature 5.8S rRNA. The fact that we failed to detect any interaction between p14 ARF and human 5.8S rRNA in vitro as well as in vivo, strongly argues in favor of the existence of alternative pathways (Andrique et al., 2005) . In that manner, p19 ARF has no effect on de novo transcription of rRNA (Savkur and Olson, 1998) , so the regulation at the transcriptional level could be p14 ARF -specific. Thus, two complementary mechanisms could participate in the control of ribosome biogenesis via p14 ARF : one regulating the transcription of the 47S precursor and another one occurring during the maturation process.
Our attempts to demonstrate a functional interaction between p14 ARF , through its stimulatory effect and Topo I, through its apoptotic endonuclease activity, were unsuccessful Ayrault et al., 2003) . However, in H358/Tet On/p14 ARF cells overexpressing p14 ARF , the formation of the p14 ARF -Topo I complex was again strictly correlated with cell cycle arrest (72 h for clone 19) reinforcing its putative involvement in the control of proliferation, independently of ribosome biogenesis.
A key regulator for the transcription of the 47S/45S pre-RNA by the RNA polymerase I (Pol I) is the transcription factor UBF. UBF specifically binds the promoter thus allowing subsequent association of transcriptional factors (SLI), and associated proteins (TAF, TBP), all of which being required for the RNA Pol I activity (for a review see Moss and Stefanovsky, 2002) . We performed immunofluorescence experiments As expected, Arf and UBF were both nucleolar. At higher resolution, UBF was found colocalized with Arf in the granular component, whereas it is generally localized in the dense fibrillar centers of the nucleolus where the pre-rRNA transcription occurs. This unusual UBF localization can be explained as a consequence of its sequestration by Arf in the granular component of the nucleolus, thus reducing its ability to activate the rRNA transcription. Indeed, part of the nucleolar Arf has been shown to reside at the fibrillar/granular junction of the nucleolus (Weber et al., 1999) , suggesting that Arf could shuttle between these two compartments to interact with other factors. A similar mechanism can be evoked to explain how the nucleoplasmic tumor suppressor pRb can directly interact with UBF in the fibrillar center of the nucleolus (Voit et al., 1997 Another essential step in the sequential setting of the transcription machinery is the association between SL1 and UBF1. This association is strictly dependent on UBF1 phosphorylation by specific CDK/cycline complexes (Grummt, 1999) . Phosphorylation on Ser-484 is, as for p14 ARF , involved in the control of the G1/S transition whereas phosphorylation on Ser-388 occurs during the S phase (Voit and Grummt, 2001) . In H358 cells, increased p14 ARF expression is correlated with a significant decrease of UBF1 phosphorylation on both Ser-484 and 388. However, this effect can be balanced by ectopic UBF1 expression leading to efficient rRNA transcription. Taken together, these data strongly support a tight involvement of p14 ARF and UBF1 in the regulation of this mechanism, and enhance the notion that the p14 ARF -dependant control of rRNA transcription could constitute an alternative pathway in the negative control of cell cycle.
Eukaryotic ribosomes assembly in the nucleolus is a multistep process whose regulation is crucial for cellular growth and proliferation. Deregulation of protein synthesis machinery through ribosomes functions or deregulation of ribosome biogenesis itself can contribute to tumorigenesis. Among tumor suppressors that might negatively regulate malignant progression by altering rRNA expression, Arf has been involved in the negative control of rRNA maturation (Itahana et al., 2003; Sugimoto et al., 2003) .
Our current results indicate that p14 ARF can also interfere with ribosome biogenesis through upstream mechanisms. An explanation could be that p14 ARF through its direct or indirect interaction with UBF1 on the rRNA promoter, prevents the phosphorylation required for subsequent association between UBF1 and the transcription factor SL1. Upon p14 ARF overexpression, the setting-up of the transcriptional machinery complex is altered and consequently, the transcription of the 47S rRNA precursor is inhibited. Topo I is not involved in this model as immunoprecipitation experiments did not allow us to detect Topo I/ UBF1 physical complex.
Materials and methods
Cell lines
Mammalian cells were grown (371C, 5% CO 2 ) in Dulbecco's modified Eagle's medium (293, human embryonic kidney cells) or RPMI 1640 (H358, human bronchialveolar carcinoma cells) supplemented with fetal bovine serum and antibiotics (Invitrogen Ltd, UK).
H358/Tet-On/p14 ARF inducible clone (clone 19) was obtained using a modified doxycyclin-regulated inducible expression system (Tet-On System, Clontech, Ozyme, France) as previously described (Eymin et al., 2003) . p14
ARF expression was induced in the presence of 1 mg/ml doxycyclin (SIGMA-ALDRICH, France).
Plasmids
Expression vectors for Arf, E2F1 and UBF p14 ARF cDNA was prepared as previously described (Ayrault et al., 2003) and cloned into the BamHI and XbaI sites of pcDNA3.1 (Invitrogen). Construction of pcDNA-E2F1 and pcDNA-UBF has been previously described (Eymin et al., 2001; Huang et al., 2002) .
Luciferase vectors All the luciferase constructs (Luc) were kindly provided by Dr S Jacob (Ghoshal et al., 2004) : pIRESLuc was constructed by replacing the Kozak sequence of a pGL3-basic vector (Promega, France) with the IRES and is used as a negative control vector. The human rRNA promoter sequence (À410/ þ 314) comprising the UCE, core promoter and part of ETS1, was cloned upstream the IRES-Luc and named pHrDNA-IRES-Luc. pRLTK corresponds to renilla luciferase reporter, driven by HSV-TK promoter (Promega, France).
Transfection Transient transfection
At 24 h before transfection, H358wt cells were subcultured and seeded in six-well plates (4.10 5 cells/ well). Cells were transfected with 0.5 or 1 mg of empty vector (pcDNA3.1), pcDNA3.1-p14 ARF or pcDNA3.1-E2F1 with Effectene transfection reagent (Qiagen S.A., France), in the presence of 10% serum. At 48 h after transfection, cells were washed in 1 Â phosphate-buffered saline (PBS), resuspended in lysis buffer (Tris-HCl 10 mM pH7.5, NaCl 120 mM, ethylenediamine-N, N, N 0 , N 0 -tetraacetic acid (EDTA) 1 mM, dithiothreitol 1 mM, NP40 0.5%, sodium dodecyl sulfate (SDS) 0.1%, phenylmethylsulphonyl fluoride (PMSF) 1 mM, supplemented with protease inhibitor cocktail (Roche, Roche p14 ARF negatively regulates rRNA transcription O Ayrault et al
